Gene Therapy in Ophthalmology


Gene therapy in ophthalmology is propelling transformative advancements, offering hope for treating inherited eye diseases. This personalized precision approach, facilitated by emerging viral vector technologies, holds promise in restoring vision for those affected by conditions like Leber congenital amaurosis (LCA), retinitis pigmentosa, and choroideremia. Clinical successes underscore its potential, as patients have shown remarkable improvements, perceiving light, shapes, and even reading letters on an eye chart post-treatment.



Collaborative efforts among geneticists, ophthalmologists, and researchers fuel the field's progress. While challenges persist, such as refining vector delivery and ensuring affordability, gene therapy's trajectory promises a future where untreatable eye conditions can be managed or even cured through gene-based interventions. 


    Related Conference of Gene Therapy in Ophthalmology

    March 18-19, 2024

    5th World Congress on Ophthalmology and Vision Science

    Zurich, Switzerland
    April 25-26, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    May 09-10, 2024

    7th International Eye and Vision Congress

    Barcelona, Spain
    May 16-17, 2024

    8th World Congress on Eye and Vision

    Rome, Italy
    June 13-14, 2024

    9th International Conference on Eye and Vision

    Barcelona, Spain
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain

    Gene Therapy in Ophthalmology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in